Journal articles on the topic 'Roflumilast'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Roflumilast.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Yosipovitch, Gil, Shawn Kwatra, James Del Rosso, et al. "Reduction in Pruritus Across Indications in Phase 3 Trials of Topical Roflumilast." SKIN The Journal of Cutaneous Medicine 9, no. 4 (2025): s587. https://doi.org/10.25251/579nct27.
Full textLivingston, Nicholas R., Peter CT Hawkins, James Gilleen, et al. "Preliminary evidence for the phosphodiesterase type-4 inhibitor, roflumilast, in ameliorating cognitive flexibility deficits in patients with schizophrenia." Journal of Psychopharmacology 35, no. 9 (2021): 1099–110. http://dx.doi.org/10.1177/02698811211000778.
Full textAlispahic, Imane Achir, Rikke Sørensen, Josefin Eklöf, et al. "Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations." Journal of Clinical Medicine 9, no. 5 (2020): 1442. http://dx.doi.org/10.3390/jcm9051442.
Full textNicolas, Samar E., Michael D. Bear, Abir O. Kanaan, Oana Andreia Coman, and Lorena Dima. "Roflumilast 0.3% Cream: a Phosphodiesterase 4 Inhibitor for the Treatment of Chronic Plaque Psoriasis." American Journal of Therapeutics 30, no. 6 (2023): e535-e542. http://dx.doi.org/10.1097/mjt.0000000000001678.
Full text&NA;. "Roflumilast." Drugs in R & D 5, no. 3 (2004): 176–81. http://dx.doi.org/10.2165/00126839-200405030-00009.
Full textSanford, Mark. "Roflumilast." Drugs 70, no. 12 (2010): 1615–27. http://dx.doi.org/10.2165/11205930-000000000-00000.
Full textChristie, P. "Roflumilast." Drugs of Today 41, no. 10 (2005): 667. http://dx.doi.org/10.1358/dot.2005.41.10.920428.
Full textCada, Dennis J., Terri L. Levien, and Danial E. Baker. "Roflumilast." Hospital Pharmacy 46, no. 8 (2011): 597–606. http://dx.doi.org/10.1310/hpj4608-597.
Full textFabbri, Leonardo M., Bianca Beghé, Uma Yasothan, and Peter Kirkpatrick. "Roflumilast." Nature Reviews Drug Discovery 9, no. 10 (2010): 761–62. http://dx.doi.org/10.1038/nrd3276.
Full textSorbera, L. A., P. A. Leeson, and J. Castañer. "Roflumilast." Drugs of the Future 25, no. 12 (2000): 1261. http://dx.doi.org/10.1358/dof.2000.025.12.604045.
Full textCao, Hong-Ying, Tian-Hua Yu, Cui-Hong Han, Wen-Wu Liu, Pei-Xi Zhang, and Peng Tang. "Roflumilast, a phosphodiesterase-4 inhibitor, improves hyperoxia-induced lung injury via anti-inflammation." Undersea and Hyperbaric Medicine 47, no. 2 (2020): 189–96. http://dx.doi.org/10.22462/04.06.2020.3.
Full textRehman, Najeeb Ur, Mohd Nazam Ansari, and Abdul Samad. "In Silico, Ex Vivo and In Vivo Studies of Roflumilast as a Potential Antidiarrheal and Antispasmodic agent: Inhibition of the PDE-4 Enzyme and Voltage-gated Ca++ ion Channels." Molecules 25, no. 4 (2020): 1008. http://dx.doi.org/10.3390/molecules25041008.
Full textMaiga, Mariama C., Bintou Ahmadou Ahidjo, Mamoudou Maiga, and William R. Bishai. "Roflumilast, a Type 4 Phosphodiesterase Inhibitor, Shows Promising Adjunctive, Host-Directed Therapeutic Activity in a Mouse Model of Tuberculosis." Antimicrobial Agents and Chemotherapy 59, no. 12 (2015): 7888–90. http://dx.doi.org/10.1128/aac.02145-15.
Full textOctafia, Ita, Dwi Octamy Sari, Novi Wulandari, et al. "Roflumilast: A Review of Chronic Obstructive Pulmonary Disease (COPD) Treatment." Qanun Medika - Medical Journal Faculty of Medicine Muhammadiyah Surabaya 5, no. 1 (2021): 35. http://dx.doi.org/10.30651/jqm.v5i1.5043.
Full textMurad, Hussam A., Hamed S. Habib, Misbahuddin M. Rafeeq, Mansour I. Sulaiman, Amer S. Abdulrahman, and Mohamad Nidal Khabaz. "Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice." Experimental Biology and Medicine 242, no. 5 (2017): 516–26. http://dx.doi.org/10.1177/1535370216685006.
Full textPeng, Sheng, Hong-Zhu Yan, Pei-Rong Liu, et al. "Phosphodiesterase 4 Inhibitor Roflumilast Protects Rat Hippocampal Neurons from Sevoflurane Induced Injury via Modulation of MEK/ERK Signaling Pathway." Cellular Physiology and Biochemistry 45, no. 6 (2018): 2329–37. http://dx.doi.org/10.1159/000488180.
Full textWang, Hao, Fang-fang Zhang, Yong Xu, et al. "The Phosphodiesterase-4 Inhibitor Roflumilast, a Potential Treatment for the Comorbidity of Memory Loss and Depression in Alzheimer’s Disease: A Preclinical Study in APP/PS1 Transgenic Mice." International Journal of Neuropsychopharmacology 23, no. 10 (2020): 700–711. http://dx.doi.org/10.1093/ijnp/pyaa048.
Full textSmythe, Ciaran, Alice Sohn, Eingun James Song, and George Michael Lewitt. "Successful Treatment of Seborrheic Dermatitis with Topical Roflumilast: A Case Series." SKIN The Journal of Cutaneous Medicine 8, no. 5 (2024): 1889–92. http://dx.doi.org/10.25251/skin.8.5.20.
Full textPamila, Miss, Ramya Sugumar, and Darling Chellathai David. "Evaluation of Roflumilast (BCRP inhibitor) and Methotrexate (BCRP substrate) on Viability of Primary Squamous Cell Carcinoma – An in vitro Study." Biomedical and Pharmacology Journal 12, no. 2 (2019): 683–87. http://dx.doi.org/10.13005/bpj/1689.
Full textSimpson, Eric, Lawrence Eichenfield, James Del Rosso, et al. "Roflumilast Cream 0.15% in Patients with Atopic Dermatitis: Individual Patient Response from the Pooled INTEGUMENT-1 and INTEGUMENT-2 Phase 3 Trials." SKIN The Journal of Cutaneous Medicine 8, no. 2 (2024): s372. http://dx.doi.org/10.25251/skin.8.supp.372.
Full textTyrrell, Jean, Xiaozhong Qian, Jose Freire, and Robert Tarran. "Roflumilast combined with adenosine increases mucosal hydration in human airway epithelial cultures after cigarette smoke exposure." American Journal of Physiology-Lung Cellular and Molecular Physiology 308, no. 10 (2015): L1068—L1077. http://dx.doi.org/10.1152/ajplung.00395.2014.
Full textKazmi, Imran, Fahad A. Al-Abbasi, Muhammad Afzal, Muhammad Shahid Nadeem, Hisham N. Altayb, and Gaurav Gupta. "Phosphodiesterase-4 Inhibitor Roflumilast-Mediated Protective Effect in Sepsis-Induced Late-Phase Event of Acute Kidney Injury: A Narrative Review." Pharmaceuticals 15, no. 7 (2022): 899. http://dx.doi.org/10.3390/ph15070899.
Full textGooderham, Melinda, Jerry Bagel, Seth Forman, et al. "Patient-Reported Outcomes with Roflumilast Foam 0.3% in Patients with Psoriasis of the Scalp and Body in the Phase 3 ARRECTOR Trial." SKIN The Journal of Cutaneous Medicine 9, no. 2 (2025): s525. https://doi.org/10.25251/skin.10.supp.525.
Full textDel Rosso, James, H. Chih-ho Hong, Leon Kircik, et al. "Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Individual Patient Response from the Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials." SKIN The Journal of Cutaneous Medicine 8, no. 1 (2024): s310. http://dx.doi.org/10.25251/skin.8.supp.310.
Full textLebwohl, Mark G., Leon H. Kircik, Angela Y. Moore, et al. "Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis." JAMA 328, no. 11 (2022): 1073. http://dx.doi.org/10.1001/jama.2022.15632.
Full textZeng, Shasha, Haibing Bai та Mi Zou. "Effects of Roflumilast on Patients with Chronic Obstructive Pulmonary Disease Treated with Inhaled Corticosteroid/Long-Acting β2 Agonist: A Meta-analysis". Computational and Mathematical Methods in Medicine 2022 (23 липня 2022): 1–9. http://dx.doi.org/10.1155/2022/8101099.
Full textHassan, Ghida, Sherif A. Kamar, Hagar Yousry Rady, Dina Sayed Abdelrahim, Nesma Hussein Abdel Hay Ibrahim, and Noha N. Lasheen. "A study of roflumilast treatment on functional and structural changes in hippocampus in depressed Adult male Wistar rats." PLOS ONE 19, no. 2 (2024): e0296187. http://dx.doi.org/10.1371/journal.pone.0296187.
Full textBotrugno, Rachel, Bijaya Rajlawat, Daniel Finn, and Paul Devakar Yesudian. "P099 Use of roflumilast in erosive oral inflammatory conditions." British Journal of Dermatology 191, Supplement_1 (2024): i62—i63. http://dx.doi.org/10.1093/bjd/ljae090.126.
Full textSyfridiana, Rafina, and Fauna Herawati. "Roflumilast: Review of Phosphodiesterase-4 Inhibitor as Asthma Therapy." Journal of Health Sciences 14, no. 3 (2021): 214–21. http://dx.doi.org/10.33086/jhs.v14i3.2114.
Full textPrasad, N. Nukendra, R. Venkata Nadh, and N. Srinivasu. "Validated HPLC Method for Assay and Content Uniformity Testing of Roflumilast in Blend and Tablets." Asian Journal of Chemistry 32, no. 6 (2020): 1279–85. http://dx.doi.org/10.14233/ajchem.2020.22373.
Full textIzquierdo, J. L., and J. Aparicio. "Roflumilast for COPD." Drugs of Today 46, no. 11 (2010): 823. http://dx.doi.org/10.1358/dot.2010.46.11.1521831.
Full textWorndl, Erin, Eoin B. Hunt, Marcus P. Kennedy, Michael T. Henry, Barry J. Plant, and Desmond M. Murphy. "Roflumilast in COPD." Chest 148, no. 1 (2015): e31. http://dx.doi.org/10.1378/chest.15-0664.
Full textChu, David, Brett Stephenson, Jeff Lee, et al. "Clinical Efficacy and Patient Reported Impacts of Roflumilast Foam 0.3% in Seborrheic Dermatitis: An Analysis of STRATUM Data for Patients Unresponsive or Intolerant to Topical Corticosteroids." SKIN The Journal of Cutaneous Medicine 8, no. 2 (2024): s397. http://dx.doi.org/10.25251/skin.8.supp.397.
Full textGuitard, Nathalie, Florent Raffin, and François-Xavier Boittin. "The Phosphodiesterase 4 Inhibitor Roflumilast Protects Microvascular Endothelial Cells from Irradiation-Induced Dysfunctions." Cells 14, no. 13 (2025): 1017. https://doi.org/10.3390/cells14131017.
Full textLee, Byung-Cheol, Seiko Susuki-Miyata, Chen Yan, and Jian-Dong Li. "Dexamethasone Inhibits Synergistic Induction of PDE4B Expression by Roflumilast and Bacterium NTHi." International Journal of Molecular Sciences 19, no. 11 (2018): 3511. http://dx.doi.org/10.3390/ijms19113511.
Full textDOMINGUES, ERIK. "Recalcitrant Scalp Psoriasis Successfully Treated with Once-Daily Roflumilast Cream 0.3%." SKIN The Journal of Cutaneous Medicine 8, no. 6 (2024): s417. http://dx.doi.org/10.25251/skin.8.supp.417.
Full textBlauvelt, Andrew, Javier Alonso-Llamazares, Neal Bhatia, et al. "Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial." SKIN The Journal of Cutaneous Medicine 7, no. 2 (2023): s196. http://dx.doi.org/10.25251/skin.7.supp.196.
Full textMatencio, Adrián, Samanta Hernández-García, Francisco García-Carmona, and José Manuel López-Nicolás. "A Way to Increase the Bioaccesibility and Photostability of Roflumilast, a COPD Treatment, by Cyclodextrin Monomers." Polymers 11, no. 5 (2019): 801. http://dx.doi.org/10.3390/polym11050801.
Full textField, Stephen K. "Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations." Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 5 (January 2011): CCRPM.S7049. http://dx.doi.org/10.4137/ccrpm.s7049.
Full textBunick, Christopher, Neal Bhatia, James Del Rosso, et al. "Investigator- and Patient-Rated Local Tolerability in Phase 3 Trials of Topical Roflumilast in Patients With Psoriasis, Seborrheic Dermatitis, and Atopic Dermatitis." SKIN The Journal of Cutaneous Medicine 8, no. 1 (2024): s309. http://dx.doi.org/10.25251/skin.8.supp.309.
Full textSuzuki, Osamu, Taiji Goto, Toshiharu Yoshino, Satoshi Nakamura, and Hiroaki Maeda. "The role of phosphodiesterase 4B in IL-8/LTB4-induced human neutrophil chemotaxis evaluated with a phosphodiesterase 4B inhibitor." Acta Pharmaceutica 65, no. 2 (2015): 191–97. http://dx.doi.org/10.1515/acph-2015-0016.
Full textSi, Yu Hui, Gang Chun Sun, Ge Song, Wen Peng Mai, and Zhi Cheng Li. "Synthesis and Characterization of Novel Roflumilast Analogues." Advanced Materials Research 781-784 (September 2013): 1190–93. http://dx.doi.org/10.4028/www.scientific.net/amr.781-784.1190.
Full textDuque, Adolfo E. Diaz, Pedro S. S. M. Ferrari, Purushoth Ethiraj, et al. "First-Line Combination of R-CHOP with the PDE4 Inhibitor Roflumilast for High-Risk DLBCL." Cancers 16, no. 22 (2024): 3857. http://dx.doi.org/10.3390/cancers16223857.
Full textLim, Je-Oh, Woong-Il Kim, Se-Jin Lee, et al. "The Involvement of PDE4 in the Protective Effects of Melatonin on Cigarette-Smoke-Induced Chronic Obstructive Pulmonary Disease." Molecules 26, no. 21 (2021): 6588. http://dx.doi.org/10.3390/molecules26216588.
Full textArkhipov, V. V. "Clinical pharmacology of roflumilast." Russian Pulmonology, no. 2 (January 1, 2012): 90–98. http://dx.doi.org/10.18093/0869-0189-2012-0-2-90-98.
Full textRho, Jason, Nancy Ho, and Vinay Prasad. "Roflumilast in COPD: Response." Chest 148, no. 1 (2015): e31-e32. http://dx.doi.org/10.1378/chest.15-0837.
Full textCortijo Gimeno, Julio, and Esteban Morcillo Sánchez. "Perfil farmacológico del roflumilast." Archivos de Bronconeumología 46 (January 2010): 19–24. http://dx.doi.org/10.1016/s0300-2896(10)70052-1.
Full textIzquierdo Alonso, José Luis. "Perfil clínico del roflumilast." Archivos de Bronconeumología 46 (January 2010): 25–32. http://dx.doi.org/10.1016/s0300-2896(10)70053-3.
Full textGupta, Steve. "Side-effects of roflumilast." Lancet 379, no. 9817 (2012): 710–11. http://dx.doi.org/10.1016/s0140-6736(12)60304-3.
Full textCarraro, Chiara Francesca. "Two cases of COPD benefitting from therapy with roflumilast." Monaldi Archives for Chest Disease 79, no. 3-4 (2015). http://dx.doi.org/10.4081/monaldi.2013.29.
Full text